who is not a candidate for glp 1 good who should not take glp 1 drugs 7 Alternatives to GLP-1s if

Patients at Risk for Bleeding The elderly and patients with obesity are most affected by the increased bleeding risk when combining GLP-1R agonists with antithrombotic drugs such as aspirin, clopidogrel, or direct oral anticoagulants (DOACs)

When Switching Makes Clinical Sense If you are stable on Ozempic or Trulicity with an HbA1c at goal, switching to Mounjaro may not be clinically justified, and TRICARE is unlikely to approve the PA

That documentation, along with a current clinical note, must be reviewed by your AME using the FAAs CACI Weight Loss Management Worksheet

Who Benefits Most from Medical Weight Loss

What is most important is staying consistent and following the protocol assigned by the provider since steady adherence leads to the best long-term outcomes